Microbiology explores the invisible world of tiny life forms that shape our health, environment, and even the air we breathe. From bacteria and viruses to fungi and parasites, this field investigates how these microscopic organisms interact with us and each other, driving everything from disease outbreaks to beneficial fermentation processes. Understanding them is crucial for developing new medicines, improving food safety, and combating global health challenges.

At Gist.Science, we make the latest discoveries in this dynamic field accessible to everyone. We process every new preprint uploaded to bioRxiv in this category, transforming dense academic findings into both clear, plain-language explanations and detailed technical summaries. This ensures that whether you are a student, a researcher, or simply curious, you can grasp the significance of cutting-edge science without getting lost in jargon.

Below are the most recent papers in microbiology, curated and summarized directly from the bioRxiv server to keep you at the forefront of discovery.

🦠 microbiology

Microbiota-derived indole limits Campylobacter jejuni colonization by inhibiting respiration and metabolism

This study demonstrates that microbiota-derived indole inhibits *Campylobacter jejuni* colonization in the inflamed gut by suppressing key respiratory and metabolic pathways, thereby revealing a critical mechanism by which commensal bacteria naturally limit this pathogen's growth.

Sinha, R., Bhattarai, B., Zimpel, C. K., Ottosen, E., LeVeque, R. M., Singh, P., DiRita, V. J.2026-04-29
🦠 microbiology

Distinct virus-derived circular RNA molecule influences host response during SARS-CoV-2 infection

This study identifies and characterizes a novel SARS-CoV-2-derived circular RNA molecule, circ7b8N, which is conserved across variants, modulates host gene expression independently of viral infection, and serves as a promising biomarker for detecting both acute and post-acute infections.

Grossi-Soyster, E. N., Gullberg, R. C., Rustagi, A., Lee, J. S., Blish, C. A., Cherry, S., Salzman, J., Sarnow, P.2026-04-28
🦠 microbiology

Omicron evolution drives increased ciliated cell tropism and dysfunction in nasal epithelia.

This study demonstrates that while SARS-CoV-2 Omicron variants (BA.1, BA.5, XBB) exhibit increased tropism for nasal ciliated cells and induce apoptosis compared to ancestral strains, later variants like BA.5 and XBB uniquely drive profound ciliary dysfunction through the downregulation of assembly genes and loss of motility proteins without causing overt cilia loss.

Mostafavi, H., Parry, R., McCallum, G., Sng, J. D. J., Joensuu, M., Short, K. R., Slonchak, A., Khromykh, A.2026-04-27
🦠 microbiology

Anopheles stephensi bionomics and epidemiology in Ethiopia: A systematic review and meta-analysis with implications for urban malaria control

This systematic review and meta-analysis reveals that the invasive malaria vector *Anopheles stephensi* has rapidly expanded across Ethiopia, reaching proportions as high as 51–73% in certain regions and necessitating urgent, region-specific urban malaria control strategies.

Wakuma, T. B., Wakgari, K. L., Gutema, A. D., Jinfessa, L. R.2026-04-26
🦠 microbiology

Convergent lignocellulose degradation in terrestrial crabs is driven by distinct host genus-specific microbial communities

This study demonstrates that the gut microbiomes of terrestrial crabs are primarily structured by host genus identity, which has led to the convergent evolution of distinct microbial communities that independently acquired similar functional capabilities for lignocellulose degradation to support dietary shifts associated with terrestrial adaptation.

Watson-Zink, V. M., Wilkins, L. G. E., Eisen, J. A., Grosberg, R. K., Ettinger, C. L.2026-04-25
🦠 microbiology

Validating Conditionally Essential Targets: Discovery of the First Orally Effective Biotin Inhibitor against MycobacteriumTuberculosis

This study reports the discovery and validation of C48, the first orally effective inhibitor of the Mycobacterium tuberculosis biotin biosynthesis enzyme BioA, which demonstrated significant in vivo efficacy in a novel low-biotin mouse model designed to overcome the limitations of standard preclinical testing.

Liu, Q., Wallach, J. B., Jayasinghe, Y. P., Sullivan, M. R., Proietto, J., Rodriguez, S., Vo, S., Boshoff, H. I. M., Jia (…)2026-04-24